0001179110-18-009415.txt : 20180703 0001179110-18-009415.hdr.sgml : 20180703 20180703193350 ACCESSION NUMBER: 0001179110-18-009415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180228 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolff Henry Ward CENTRAL INDEX KEY: 0001302390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 18939120 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 4 1 edgar.xml FORM 4 - X0306 4 2018-02-28 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001302390 Wolff Henry Ward SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 6.80 2018-02-28 4 A 0 37500 0 A 2028-02-28 Common Stock 37500 37500 D Stock Option (Right to Buy) 2.12 2018-06-29 4 A 0 6250 0 A 2028-06-29 Common Stock 6250 6250 D The option shall vest and become exercisable in twenty-four (24) equal monthly installments over a two (2) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date. The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date. /s/William P. Quinn (Attorney-in-Fact) 2018-07-02